Varex Imaging launches second unit at AMTZ
The new facility houses two advanced manufacturing lines — India's first manufacturing line for Cesium Iodide (CsI)— a critical material used to enhance digital X-ray image quality while reducing radiation exposure, and another line for medical-grade glass tubes, essential to X-ray and CT imaging systems. These technologies are being localised in India for the first time, bringing the full imaging hardware value chain under one roof.
Dr. Jitendra Sharma, MD and Founder-CEO of AMTZ called the development, 'A strategic move that not only elevates India's manufacturing capabilities in medical imaging but also validates AMTZ's role as a global MedTech innovation hub.'
According to a press statement from AMTZ, this strategic expansion reinforces Varex's long-term commitment to India's MedTech sector, and also supports the country's ambition to become a global hub for imaging technology and innovation.
The ground breaking ceremony was attended by Dr. Jitendra Sharma, Andrew Hartman, Global Senior Vice President – Detectors, Varex Imaging Corporation and Vivek Phalle, Senior MD and Country Head, Varex Imaging India.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
7 days ago
- Time of India
License overload, inconsistent regulations hurting healthcare businesses: NATHEALTH
New Delhi: Calling for a complete overhaul of the existing regulatory and licensing framework in India, industry representative NATHEALTH flagged that the country's 'complex regulatory structure is creating compliance bottlenecks for the healthcare sector and preventing ease of doing business.' In a meeting with the Niti Aayog members, the lobby group presented a whitepaper highlighting that, healthcare industry is one of the 'top three' regulated sectors in India, where 60 per cent of regulations are decentralized, thereby leading to complexity of compliance due to lack of standardization. The white ciphered co-authored by EY covers three sectors in healthcare viz hospitals, diagnostics and medtech and underlines that businesses operating under these segments face multiple or numerous licensing requirements and are struggling with a highly dynamic and changing regulatory landscape with little or no transition time. Speaking to media after their meeting with Niti Aayog, Ameera Shah, President, NATHEALTH, said, 'Under the white paper we have highlighted that regulatory standards vary frequently across different states, and there is often a lack of clarity regarding these regulations.' 'Among the segments, there are variations, with diagnostics being less regulated, while hospitals and medtech face much stricter regulations,' Shah added. Sharing the MedTech-related concerns raised during the meeting, Himanshu Baid, Vice President, NATHEALTH, said, 'Being classified as drugs, MedTech products are overregulated and at the meet we highlighted the Quality Control Orders (QCOs), which are hampering the manufacturing of medical devices in the country.' 'We also highlighted issues such as the overlap between government departments and labeling challenges, where we are regulated by both the CDSCO and the Ministry of Consumer Affairs, " Baid added. On Niti Aayog's response, Baid apprised, 'NITI was very receptive to the issues raised, and we will meet again in about eight weeks with concrete solutions and for further discussions.' Secondly Niti Aayog shares NATHEALTH's view that there should be a separate Act for medical devices, he added. As per Shah, the whitepaper shared with the government policy think tanks includes a total of 70 regulatory and licensing challenges of which 12 have highlighted as the 'top challenges which require urgent attention.' For hospitals the whitepaper outlines issues like state registrations for medical practitioners leading to multiple UIN generations and administrative burden, Licensing of blood banks required for central and state licensing authorities, among several others. Similarly for the other two segments diagnsotics and MedTech it includes Lack of standardization in clinical establishment regulations across states, different licensing authorities based on activity and class of device leading to multiple registrations and delays. Besides these issues the papers includes two long standing agnostics issues related to the restriction on hospital building heights that is stated to reduce the number of hospitals bed capacity and concerns over stringent penalties imposed in case of failure to obtain or renew consent in a timely manner. Among its key recommendations, the whitepaper features short, medium and long term suggestions for addressing them including single window clearance, adoption of global standards–ISO and embracing digitization— health records, signatures. 'We seek government support to address these hurdles, which will help the sector grow faster and improve patient access,' Shah noted.
Time of India
27-07-2025
- Time of India
Late Bhanutai Gadkari Memorial Diagnostic Centre inaugurated: MRI at Rs1,200, CT Scan at Rs800, X-ray at Rs100
Nagpur: A state-of-the-art 6,000 sq ft facility in north Nagpur will be offering essential diagnostic and dialysis services at some of the lowest rates in the country — MRI for Rs1,200, CT Scan for Rs800, and digital X-ray for just Rs100, and major blood tests at Rs300, which otherwise cost thousands. Remarkably, it is India's first diagnostic centre equipped entirely with "Made-in-India" machines. The late Bhanutai Gadkari Memorial Diagnostic Centre, which was inaugurated on Sunday, has come as a major boost for healthcare infrastructure in north Nagpur. Located at Kamal Chowk, Lashkaribagh, the centre is dedicated to memory of Bhanutai Gadkari, mother of Union minister for road transport and highways, Nitin Gadkari, who presided over the programme when chief minister Devendra Fadnavis inaugurated the facility. "This diagnostic centre will be a milestone in the healthcare sector. Combining empathy with service, it sets an example of how indigenous technology can be used to bring down the cost of essential diagnostics for the common man," said Fadnavis while praising Gadkari's initiative. Gadkari, on an emotional note, said that the centre is not a commercial project, but a service mission inspired by his mother's legacy for compassion and empathy. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Your IQ Is 140 If You Can Answer 10 of These Questions Correctly. IQ International Undo by Taboola by Taboola "From my first day in public life, her blessings guided me to serve the poor and suffering," said Gadkari and made an appeal to include bone marrow, sickle cell and thalassaemia treatments under the Mahatma Jyotiba Phule Jan Arogya Yojana. The fully air-conditioned centre, run by the late Bhanutai Gadkari Gramin Vikas Sanstha, features a modern waiting area, paperless operations, high-capacity servers, and trained technical staff. All MRI and CT scan machines have been manufactured in India, in collaboration with AMTZ (Andhra Pradesh MedTech Zone), significantly cutting costs compared to imported equipment. "This is the first time in India that a diagnostic centre has been established with 100% indigenous machines. We used to import MRI machines for Rs6 crore. Now, we are making them at Rs2 crore and exporting them too," said Dr Jitendra Sharma, managing director of AMTZ. # WHAT CENTRE OFFERS MRI – Rs1,200: High-end 1.5 Tesla imaging with 16-channel MUSIC technology ensuring quick scans with excellent image quality CT Scan — Rs800: BIS, AERB and CDSCO-approved fast scanning machines. Full chest scans done in just 6 seconds Digital X-ray — Rs100; high-resolution, modern digital imaging Dialysis — Rs750 standard, only Rs250 if NMC provides ₹500 subsidy—free dialysis for donor-backed patients Pathology Tests — Rs300; over 40 common tests included Pharmacy — Generic medicines available at 10% discount
Hans India
26-07-2025
- Hans India
Second advanced manufacturing facility at AMTZ
Visakhapatnam: Ina major boost to India's medical imaging capabilities, Varex Imaging Manufacturing India Private Limited started its second advanced manufacturing facility at Andhra Pradesh MedTech Zone (AMTZ) campus in Visakhapatnam on Friday. The strategic expansion not only reinforces the company's long-term commitment to India's MedTech sector but also advances the country's ambition to become a global hub for imaging technology and innovation. Welcoming the expansion as a step aligned with India's Atmanirbhar Bharat vision. MD and Founder-CEO of AMTZ Jitendra Sharma termed the development as a strategic move that not only elevates India's manufacturing capabilities in medical imaging but also validates AMTZ's role as a global MedTech innovation hub. With the launch of its second facility at AMTZ, Varex is set to expand its imaging technology capabilities by establishing two advanced manufacturing lines, India's first manufacturing facility for Cesium Iodide (CsI) coating, used to enhance digital X-ray image quality while reducing radiation exposure, and another for medical-grade glass tubes essential for X-ray and CT imaging systems. These technologies, being localised for the first time in India, will bring a full imaging hardware value chain from detector fabrication to X-ray tube assembly under one roof. This pioneering move will not only boost the company's manufacturing strength but also support Indian OEMs, component suppliers, and diagnostic innovators across the country. The facility is expected to position India as a competitive exporter of imaging technologies, particularly to emerging markets and low and middle income countries. The second facility follows the successful operations of the company's first unit at AMTZ, which currently manufactures advanced flat panel detectors, a vital component in digital X-ray imaging systems. These detectors play a key role in modern diagnostics across radiography, fluoroscopy and interventional imaging and their local production is helping India reduce its reliance on imported diagnostic components. The formal groundbreaking ceremony was held in the presence of Andrew Hartman, global senior vice president – Detectors, Varex Imaging Corporation and Vivek Phalle, senior MD and country head, Varex Imaging India and Dr Jitendra Sharma.
